Compare SCHW & PM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SCHW | PM |
|---|---|---|
| Founded | 1971 | 1987 |
| Country | United States | United States |
| Employees | 32700 | N/A |
| Industry | Investment Bankers/Brokers/Service | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 167.1B | 249.9B |
| IPO Year | N/A | 2007 |
| Metric | SCHW | PM |
|---|---|---|
| Price | $92.72 | $156.21 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 18 | 9 |
| Target Price | $112.56 | ★ $188.67 |
| AVG Volume (30 Days) | ★ 8.1M | 4.0M |
| Earning Date | 04-16-2026 | 04-22-2026 |
| Dividend Yield | 1.28% | ★ 3.74% |
| EPS Growth | N/A | ★ 60.62 |
| EPS | N/A | ★ 7.26 |
| Revenue | N/A | ★ $40,648,000,000.00 |
| Revenue This Year | $12.97 | $10.78 |
| Revenue Next Year | $8.93 | $6.61 |
| P/E Ratio | ★ $20.51 | $21.65 |
| Revenue Growth | N/A | ★ 7.31 |
| 52 Week Low | $73.76 | $142.11 |
| 52 Week High | $107.50 | $191.30 |
| Indicator | SCHW | PM |
|---|---|---|
| Relative Strength Index (RSI) | 44.11 | 36.78 |
| Support Level | $90.87 | $152.40 |
| Resistance Level | $97.73 | $162.18 |
| Average True Range (ATR) | 2.85 | 3.85 |
| MACD | 0.33 | 0.10 |
| Stochastic Oscillator | 23.75 | 31.48 |
Charles Schwab is one of the largest retail-oriented financial-services companies in the US, with $11.9 trillion in client assets across its brokerage, banking, asset management, custody, financial advisory, and wealth-management businesses at the end of 2025. While best known for its retail brokerage offering, Schwab generates the lion's share of its revenue and profits through its Charles Schwab Bank and asset management segments. The firm is a dominant player in registered investment advisor custody, with over 40% market share, and has recently pushed into wealth management with robo-advisory, direct indexing, and other managed-investment solutions.
Created from the international operations of Altria in 2008, Philip Morris International sells cigarettes and reduced-risk products, including heat sticks, vapes, and oral nicotine offerings, primarily outside of the US. With the 2023 acquisition of Swedish Match, a leading manufacturer of traditional oral tobacco products and nicotine pouches primarily in the US and Scandinavia, PMI is not only dominant in smokable products but also has the Iqos and Zyn brands, which respectively dominate heated tobacco and nicotine pouches in most markets. It also owns the Veev brand in vapes.